PP
Businessman

Pankaj Patel

Born 1 January 1951 · Gujarat

Leading Zydus Lifesciences to become India's fifth largest pharmaceutical company.

Pankaj Ramanbhai Patel is an Indian billionaire businessman, and the chairman of Zydus Lifesciences, the fifth largest pharmaceutical company in India.

✨

A detail that
surprised us

“

In 2013, Zydus Lifesciences received regulatory approval for Lipaglyn, the world's first drug to treat diabetic dyslipidemia, developed under Patel's leadership.

The Story

1
🏭 In 1976, Pankaj Patel began his career by joining Cadila Healthcare, the pharmaceutical company his father co-founded in 1952 in Gujarat, marking his entry into the family business focused on vitamins.
2
⚔️ In 1995, after a split between the founding families, Patel took charge of Cadila Healthcare, then a Rs. 200 crore company with Rs. 400 crore overheads, facing the challenge of balancing costs and growth in a competitive pharma market.
3💊 By 2013, under Patel’s leadership, Zydus Lifesciences launched Lipaglyn, the world’s first drug approved to treat diabetic dyslipidemia, combining control of blood sugar and cholesterol in one medication.
4🍬 The Sugar-Free brand, developed by Patel’s Zydus Wellness division, became a ubiquitous sugar substitute in India, while their Everyuth face wash expanded the company’s presence in consumer health products.

🏅 Awards & Honours

—
Padma Bhushan

🔍 One thing most people don't know

“

At just eight years old, Patel would accompany his father to their factory, observing workers on tablet machines, an early exposure that deeply influenced his pharmaceutical career.

📸 Through the Years

📷

No photos yet

Help preserve history — add a photo of this icon

🗓️ A Life in Moments

🕊️
Birth
Birth of Pankaj Ramanbhai Patel
Pankaj Patel was born in Gujarat, India, into a family with roots in pharmaceutical entrepreneurship.
1953
⚡
Career
Joined Cadila Healthcare
After completing his pharmacy degrees, Patel joined the family business Cadila Healthcare, founded in 1952 by his father.
1976
⚡
Career
Cadila Split and Leadership
Following a family split, Patel took charge of Cadila Healthcare, facing the challenge of managing a company with Rs. 200 crore turnover but Rs. 400 crore overheads.
1995
⚡
Career
Cadila Healthcare Goes Public
The Patel family's Cadila Healthcare launched its shares publicly for the first time, marking a major step in the firm's growth.
2000
⚡
Career
Launch of Lipaglyn
Zydus Lifesciences received regulatory approval for Lipaglyn, the world’s first drug treating diabetic dyslipidemia, combining blood sugar and cholesterol control.
2013
⚡
Career
VaxiFlu-s Vaccine Approval
Zydus Lifesciences was approved to launch VaxiFlu-s, India’s first H1N1 vaccine during the swine flu outbreak, developed under Patel’s direction.
2013
🏅
Award
Padma Bhushan Award
Patel was conferred the Padma Bhushan, India’s third highest civilian award, for contributions in trade and industry.
2025
More moments to come...
+ Add a moment

🗝️Discoveries

Swipe to uncover hidden stories
01 / 04
🌍HISTORICAL IMPACT

In 1995, the original Cadila Laboratories split into two family-run companies: Cadila Healthcare (Patel’s) and Cadila Pharmaceuticals, marking a rare and complex division in a family business.

02 / 04
🏆ACHIEVEMENT

Zydus Lifesciences was among the few companies globally to develop and launch an H1N1 vaccine (VaxiFlu-s) during the swine flu crisis, beating all other Indian vaccine manufacturers.

03 / 04
🔍LESSER KNOWN

Patel holds degrees not only in pharmacy but also a Bachelor of Arts in Science and Law from the University of Mumbai, a diverse educational background unusual for pharma entrepreneurs.

No quote recorded for Pankaj Patel yet.

🎙️ Speeches & Recordings

These recordings preserve the legacy of Bharat's icons
उद्योगपति पंकज पटेल के साथ खास बातचीत Zindagi Cafe 09 09 2023

🌱 What changed because of them

Pankaj Patel transformed Zydus Lifesciences from a struggling Rs. 200 crore company into one of India’s top five pharmaceutical firms with a global footprint in 70 countries. His leadership in developing innovative drugs like Lipaglyn and India’s first H1N1 vaccine reshaped the domestic pharma industry’s capabilities in novel treatments and rapid vaccine response. Patel also expanded the company’s reach into consumer health with brands like Sugar-Free, impacting health and wellness sectors across India.

💬 Social Buzz

💬

What are people saying about Pankaj Patel?

Share posts from historians, journalists and notable voices about this icon. 🇮🇳

💭 Memories & Tributes

Share your memory of Pankaj Patel...
Loading memories...
Is this profile accurate?